Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Journal of Cancer Research and Clinical Oncology
|
May 18, 2001
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma
T Olencki, D Peereboom, L Wood, et al.
Oncogene
|
October 15, 2011
G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer
V Cheriyath, M A Kuhns, B S Jacobs, et al.
The Journal of Urology
|
February 24, 2009
Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy
D R Shepard, R Dreicer, J Garcia, et al.
Surgery
|
December 1, 1991
Eastern Cooperative Oncology Group study 1879: mitotane and adriamycin in patients with advanced adrenocortical carcinoma
R A Decker, P Elson, T F Hogan, et al.
Gynecologic Oncology
|
October 19, 2001
Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia
J Belinson, Y L Qiao, R Pretorius, et al.
JAMA
|
September 5, 1998
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
Y Xu, Z Shen, D W Wiper, et al.
Investigational New Drugs
|
August 25, 2000
Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas
T Chidiac, G T Budd, R Pelley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy
R M Bukowski, P Rayman, R Uzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2006
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
T K Choueiri, Bi Rini, J A Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings
R M Bukowski, T Olencki, H Gunn, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Journal of Cancer Research and Clinical Oncology
|
May 18, 2001
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma
T Olencki, D Peereboom, L Wood, et al.
Oncogene
|
October 15, 2011
G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer
V Cheriyath, M A Kuhns, B S Jacobs, et al.
The Journal of Urology
|
February 24, 2009
Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy
D R Shepard, R Dreicer, J Garcia, et al.
Surgery
|
December 1, 1991
Eastern Cooperative Oncology Group study 1879: mitotane and adriamycin in patients with advanced adrenocortical carcinoma
R A Decker, P Elson, T F Hogan, et al.
Gynecologic Oncology
|
October 19, 2001
Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia
J Belinson, Y L Qiao, R Pretorius, et al.
JAMA
|
September 5, 1998
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
Y Xu, Z Shen, D W Wiper, et al.
Investigational New Drugs
|
August 25, 2000
Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas
T Chidiac, G T Budd, R Pelley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy
R M Bukowski, P Rayman, R Uzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2006
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
T K Choueiri, Bi Rini, J A Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings
R M Bukowski, T Olencki, H Gunn, et al.
Page
of 6